Skip to main content

Jefferies Financial Group Inc.

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 96223 NEW YORK, NY

Position in NAMS

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$4,159,251
+$3,738,291 QoQ
Shares Held
122,728
+922.7% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#70
of 197 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NAMS Over Time

Shares Held

Position Value (USD)

Derivatives in NAMS

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$20,334,000
PutShares
600,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Jefferies Financial Group Inc. holds $677,219,224 across 66 Biotechnology names. NAMS ranks #24 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NAMS

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,159,251 122,728
2026-06-30 $20,334,000 600,000
2025-12-31 $420,960 12,000
2025-09-30 $341,280 12,000